In the majority opinion, Justice Stephen Breyer wrote that the current “regulatory language” is “ambiguous,” and future cases concerning physicians prescribing controlled substances must prove the treatment lacked a “legitimate medical purpose” and the physician knew so. Experts told CNN the ruling will make it more difficult to prosecute physicians in similar cases.
The two defendants were Xiulu Ruan, MD, and Shakeel Kahn, MD, who ran pain management practices in Alabama and Arizona, respectively, according to CNN.
Editor’s note: This article was updated June 28 at 9:35 a.m. CT.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.